JP2014502598A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014502598A5 JP2014502598A5 JP2013543468A JP2013543468A JP2014502598A5 JP 2014502598 A5 JP2014502598 A5 JP 2014502598A5 JP 2013543468 A JP2013543468 A JP 2013543468A JP 2013543468 A JP2013543468 A JP 2013543468A JP 2014502598 A5 JP2014502598 A5 JP 2014502598A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- salt
- pharmaceutical composition
- composition
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 26
- 239000008194 pharmaceutical composition Substances 0.000 claims 15
- 150000003839 salts Chemical class 0.000 claims 9
- 210000001072 colon Anatomy 0.000 claims 7
- 210000000936 intestine Anatomy 0.000 claims 7
- 239000002775 capsule Substances 0.000 claims 6
- -1 digluconate Chemical compound 0.000 claims 6
- 238000001839 endoscopy Methods 0.000 claims 6
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims 4
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 3
- 239000004386 Erythritol Substances 0.000 claims 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 3
- 238000002052 colonoscopy Methods 0.000 claims 3
- 229940009714 erythritol Drugs 0.000 claims 3
- 235000019414 erythritol Nutrition 0.000 claims 3
- 239000000314 lubricant Substances 0.000 claims 3
- 159000000003 magnesium salts Chemical class 0.000 claims 3
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims 3
- 239000004094 surface-active agent Substances 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 3
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims 2
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 claims 2
- 208000001640 Fibromyalgia Diseases 0.000 claims 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 claims 2
- BPKUDUSVDVLOPY-UHFFFAOYSA-N bisoxatin Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C(=O)NC2=CC=CC=C2O1 BPKUDUSVDVLOPY-UHFFFAOYSA-N 0.000 claims 2
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000000499 gel Substances 0.000 claims 2
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 claims 2
- 210000004877 mucosa Anatomy 0.000 claims 2
- 201000006417 multiple sclerosis Diseases 0.000 claims 2
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 claims 2
- 238000004806 packaging method and process Methods 0.000 claims 2
- 239000003566 sealing material Substances 0.000 claims 2
- 229940083037 simethicone Drugs 0.000 claims 2
- 159000000000 sodium salts Chemical class 0.000 claims 2
- 238000001356 surgical procedure Methods 0.000 claims 2
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 2
- 239000003826 tablet Substances 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 2
- LSPHULWDVZXLIL-UHFFFAOYSA-N (+/-)-Camphoric acid Chemical compound CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 claims 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 1
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 claims 1
- 229940080296 2-naphthalenesulfonate Drugs 0.000 claims 1
- XMIIGOLPHOKFCH-UHFFFAOYSA-M 3-phenylpropionate Chemical compound [O-]C(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-M 0.000 claims 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims 1
- 208000004998 Abdominal Pain Diseases 0.000 claims 1
- 206010000060 Abdominal distension Diseases 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 claims 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims 1
- 208000000668 Chronic Pancreatitis Diseases 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 1
- 206010010774 Constipation Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims 1
- 206010012735 Diarrhoea Diseases 0.000 claims 1
- 208000004232 Enteritis Diseases 0.000 claims 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims 1
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- 206010033649 Pancreatitis chronic Diseases 0.000 claims 1
- 229920002230 Pectic acid Polymers 0.000 claims 1
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 claims 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 1
- 206010071061 Small intestinal bacterial overgrowth Diseases 0.000 claims 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 claims 1
- 229940022663 acetate Drugs 0.000 claims 1
- 239000000159 acid neutralizing agent Substances 0.000 claims 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 claims 1
- 229940072056 alginate Drugs 0.000 claims 1
- 235000010443 alginic acid Nutrition 0.000 claims 1
- 229920000615 alginic acid Polymers 0.000 claims 1
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 claims 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 239000002518 antifoaming agent Substances 0.000 claims 1
- 229940009098 aspartate Drugs 0.000 claims 1
- 229940077388 benzenesulfonate Drugs 0.000 claims 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 claims 1
- 229940050390 benzoate Drugs 0.000 claims 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 1
- XMIIGOLPHOKFCH-UHFFFAOYSA-N beta-phenylpropanoic acid Natural products OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 claims 1
- 239000001639 calcium acetate Substances 0.000 claims 1
- 235000011092 calcium acetate Nutrition 0.000 claims 1
- 229960005147 calcium acetate Drugs 0.000 claims 1
- 229910000019 calcium carbonate Inorganic materials 0.000 claims 1
- 229960003563 calcium carbonate Drugs 0.000 claims 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims 1
- 239000001354 calcium citrate Substances 0.000 claims 1
- 229960004256 calcium citrate Drugs 0.000 claims 1
- 159000000007 calcium salts Chemical group 0.000 claims 1
- MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 claims 1
- 239000002771 cell marker Substances 0.000 claims 1
- 229940001468 citrate Drugs 0.000 claims 1
- 206010009887 colitis Diseases 0.000 claims 1
- 230000000112 colonic effect Effects 0.000 claims 1
- 239000002872 contrast media Substances 0.000 claims 1
- 229940061607 dibasic sodium phosphate Drugs 0.000 claims 1
- 239000004205 dimethyl polysiloxane Substances 0.000 claims 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000004064 dysfunction Effects 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 1
- 229930195712 glutamate Natural products 0.000 claims 1
- 208000007386 hepatic encephalopathy Diseases 0.000 claims 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 claims 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims 1
- 229920002674 hyaluronan Polymers 0.000 claims 1
- 229960003160 hyaluronic acid Drugs 0.000 claims 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000007937 lozenge Substances 0.000 claims 1
- 239000011777 magnesium Substances 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- 239000004337 magnesium citrate Substances 0.000 claims 1
- 229960005336 magnesium citrate Drugs 0.000 claims 1
- 235000002538 magnesium citrate Nutrition 0.000 claims 1
- 229910001425 magnesium ion Inorganic materials 0.000 claims 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 claims 1
- 239000004137 magnesium phosphate Substances 0.000 claims 1
- 229960002261 magnesium phosphate Drugs 0.000 claims 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 claims 1
- 235000010994 magnesium phosphates Nutrition 0.000 claims 1
- 229940053326 magnesium salt Drugs 0.000 claims 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims 1
- 229960003390 magnesium sulfate Drugs 0.000 claims 1
- 235000019341 magnesium sulphate Nutrition 0.000 claims 1
- 229940091250 magnesium supplement Drugs 0.000 claims 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 229940045641 monobasic sodium phosphate Drugs 0.000 claims 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims 1
- 235000019799 monosodium phosphate Nutrition 0.000 claims 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-M naphthalene-2-sulfonate Chemical compound C1=CC=CC2=CC(S(=O)(=O)[O-])=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-M 0.000 claims 1
- 235000001968 nicotinic acid Nutrition 0.000 claims 1
- 239000011664 nicotinic acid Substances 0.000 claims 1
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 229940075930 picrate Drugs 0.000 claims 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 claims 1
- 239000006187 pill Substances 0.000 claims 1
- 229950010765 pivalate Drugs 0.000 claims 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 claims 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims 1
- 229920001296 polysiloxane Polymers 0.000 claims 1
- AVTYONGGKAJVTE-OLXYHTOASA-L potassium L-tartrate Chemical compound [K+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O AVTYONGGKAJVTE-OLXYHTOASA-L 0.000 claims 1
- 239000001103 potassium chloride Substances 0.000 claims 1
- 235000011164 potassium chloride Nutrition 0.000 claims 1
- 229960002816 potassium chloride Drugs 0.000 claims 1
- 239000004224 potassium gluconate Substances 0.000 claims 1
- 235000013926 potassium gluconate Nutrition 0.000 claims 1
- 229960003189 potassium gluconate Drugs 0.000 claims 1
- 239000001472 potassium tartrate Substances 0.000 claims 1
- 229940111695 potassium tartrate Drugs 0.000 claims 1
- 235000011005 potassium tartrates Nutrition 0.000 claims 1
- 239000000741 silica gel Substances 0.000 claims 1
- 229910002027 silica gel Inorganic materials 0.000 claims 1
- 230000007142 small intestinal bacterial overgrowth Effects 0.000 claims 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 239000001509 sodium citrate Substances 0.000 claims 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims 1
- 239000000176 sodium gluconate Substances 0.000 claims 1
- 235000012207 sodium gluconate Nutrition 0.000 claims 1
- 229940005574 sodium gluconate Drugs 0.000 claims 1
- 229910001415 sodium ion Inorganic materials 0.000 claims 1
- 229910052938 sodium sulfate Inorganic materials 0.000 claims 1
- 235000011152 sodium sulphate Nutrition 0.000 claims 1
- WTWSHHITWMVLBX-DKWTVANSSA-M sodium;(2s)-2-aminobutanedioate;hydron Chemical compound [Na+].[O-]C(=O)[C@@H](N)CC(O)=O WTWSHHITWMVLBX-DKWTVANSSA-M 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 229940095064 tartrate Drugs 0.000 claims 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims 1
- 229940001496 tribasic sodium phosphate Drugs 0.000 claims 1
- 235000013337 tricalcium citrate Nutrition 0.000 claims 1
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 claims 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims 1
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42256710P | 2010-12-13 | 2010-12-13 | |
| US61/422,567 | 2010-12-13 | ||
| PCT/AU2011/001609 WO2012079118A1 (en) | 2010-12-13 | 2011-12-13 | Gastric and colonic formulations and methods for making and using them |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014502598A JP2014502598A (ja) | 2014-02-03 |
| JP2014502598A5 true JP2014502598A5 (enExample) | 2015-02-12 |
| JP6121334B2 JP6121334B2 (ja) | 2017-04-26 |
Family
ID=46243884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013543468A Expired - Fee Related JP6121334B2 (ja) | 2010-12-13 | 2011-12-13 | 胃および結腸製剤ならびにそれらを作製するための方法および使用するための方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US10092573B2 (enExample) |
| EP (1) | EP2651415B1 (enExample) |
| JP (1) | JP6121334B2 (enExample) |
| KR (1) | KR101947720B1 (enExample) |
| CN (2) | CN110200954A (enExample) |
| AU (1) | AU2011342368B2 (enExample) |
| BR (1) | BR112013014827A2 (enExample) |
| CA (1) | CA2821196C (enExample) |
| DK (1) | DK2651415T3 (enExample) |
| IL (1) | IL226831B (enExample) |
| MX (1) | MX355760B (enExample) |
| NZ (1) | NZ611868A (enExample) |
| PL (1) | PL2651415T3 (enExample) |
| SG (1) | SG191145A1 (enExample) |
| WO (1) | WO2012079118A1 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPS088702A0 (en) * | 2002-03-04 | 2002-03-28 | Borody, Thomas Julius | Electrolyte purgative |
| BR112013014827A2 (pt) | 2010-12-13 | 2016-10-04 | Antony Wettstein | formulações gástricas e colônicas e métodos para produzir e usar as mesmas |
| IN2014DN03373A (enExample) * | 2011-10-27 | 2015-06-05 | Borody Thomas J | |
| RU2015106688A (ru) | 2012-07-27 | 2016-09-20 | Редхилл Байофарма Лтд. | Препараты и способы получения препаратов для применения при опорожнении толстой кишки |
| AU2013308403B2 (en) * | 2012-08-29 | 2019-02-07 | Salix Pharmaceuticals, Inc. | Laxative compositions and methods for treating constipation and related gastrointestinal diseases and conditions |
| BR112015019776A2 (pt) | 2013-03-15 | 2017-07-18 | Braintree Laboratories Inc | comprimidos de duplo uso oral em composições farmacêuticas de sais de sulfato e métodos de uso dos comprimidos |
| JP6394142B2 (ja) * | 2013-07-25 | 2018-09-26 | 大正製薬株式会社 | 固形製剤 |
| WO2015056897A1 (ko) * | 2013-10-17 | 2015-04-23 | 강윤식 | 장 세정용 조성물 |
| KR101423005B1 (ko) | 2013-10-17 | 2014-07-28 | 강윤식 | 장 세정용 조성물 |
| CN103550212A (zh) * | 2013-11-03 | 2014-02-05 | 王显著 | 含匹可硫酸和抗坏血酸的药物组合物 |
| MX2017005883A (es) * | 2014-11-04 | 2017-11-28 | Innopharmax Inc | Administracion oral de farmacos inestables o deficientemente absorbidos. |
| GB201511255D0 (en) * | 2015-06-26 | 2015-08-12 | Colltec Ltd | Formulation |
| EP3323419B1 (en) * | 2015-07-14 | 2021-04-07 | Osaka University | Erythromycin, clarithromycin and azithromycin for treatment of myotonic dystrophy |
| CN106910184B (zh) * | 2017-01-12 | 2020-10-09 | 杭州电子科技大学 | 基于深度卷积神经网络的内窥镜图像肠道出血检测方法 |
| US10143656B1 (en) * | 2017-08-04 | 2018-12-04 | Braintree Laboratories, Inc. | Solid oral sulfate salt formulations for cleaning a colon and methods of using same |
| CN111587110A (zh) | 2018-01-12 | 2020-08-25 | 麦提麦迪制药有限公司 | 治疗慢性炎症性疾病的方法 |
| KR102111094B1 (ko) | 2018-06-18 | 2020-05-14 | 주식회사 한국팜비오 | 무수황산나트륨, 황산칼륨, 무수황산마그네슘 및 시메티콘을 포함하는 장관하제 경구투여용 고형제제 조성물 |
| CN108904808A (zh) * | 2018-08-15 | 2018-11-30 | 西安力邦医药科技有限责任公司 | 一种治疗便秘的药物组合物及其应用 |
| CN109289095B (zh) * | 2018-11-23 | 2021-03-26 | 淮海工学院 | 一种含盐酸利多卡因的肠镜凝胶剂及其制备方法 |
| US20220143079A1 (en) * | 2019-02-15 | 2022-05-12 | Seaford Pharmaceuticals Inc. | Oral administration of sodium chloride to prevent complications associated with bowel cleansing with stimulant laxatives |
| EP4093259A4 (en) * | 2020-01-20 | 2024-04-10 | Advanced Health Solutions LLC | COMPOSITIONS AND METHODS FOR IMPROVING VISIBILITY OF THE GASTROINTESTINAL TRACT DURING ENDOSCOPY PROCEDURES |
| US11554155B2 (en) | 2020-01-20 | 2023-01-17 | Advanced Health Solutions LLC | Compositions and methods for improving gastrointestinal function |
| CN111494313A (zh) * | 2020-05-25 | 2020-08-07 | 李会芳 | 一种用于母猪便秘治疗的灌肠液及其制备方法 |
| CN116322467A (zh) * | 2020-09-08 | 2023-06-23 | 吉温成像有限公司 | 估计手术的充足性 |
| JP2023549291A (ja) * | 2020-10-26 | 2023-11-22 | ブレーンツリー・ラボラトリーズ・インコーポレイテッド | 結腸洗浄のための硫酸塩製剤 |
| CN112587498A (zh) * | 2020-12-29 | 2021-04-02 | 哈尔滨瀚钧现代制药有限公司 | 多库酯钠丹蒽醌及其制备方法 |
| EP4272734A4 (en) * | 2020-12-31 | 2024-12-04 | Taejoon Pharmaceutical Co., Ltd. | SOLID ORAL FORMULATION FOR COLON CLEANSING |
| US20240423938A1 (en) * | 2023-06-26 | 2024-12-26 | Reflux Gourmet Llc | Functional gum comprising an alginate blend |
Family Cites Families (104)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA761927A (en) * | 1967-06-27 | Seeger Ernst | Benzoxazine derivatives | |
| US4186025A (en) | 1975-09-25 | 1980-01-29 | Merck & Co., Inc. | Aqueous polysaccharide composition |
| US4452779A (en) | 1982-02-03 | 1984-06-05 | Cockerill Vernon | Composition and method of treating lactating mammals |
| JPS58222020A (ja) * | 1982-06-18 | 1983-12-23 | Teijin Ltd | 前処置用下剤 |
| DK454683D0 (da) | 1983-10-03 | 1983-10-03 | Mogens Gjerloev | Tarmreguleringsmiddel til behandling af diarre hos dyr samt anvendelse heraf |
| WO1986005981A1 (en) | 1985-04-18 | 1986-10-23 | Borody Thomas J | Treatment of non-ulcer dyspepsia with bismuth salts |
| US4766004A (en) | 1986-12-19 | 1988-08-23 | Warner-Lambert Company | Crunchy, highly palatable, bulk-increasing, dietary fiber supplement composition |
| IL86859A (en) | 1987-07-10 | 1991-12-15 | E Z Em Inc | Aqueous cathartic solution containing inorganic salts |
| WO1989003219A1 (en) | 1987-10-12 | 1989-04-20 | Borody Thomas J | Improved method for treatment of gastrointestinal disorders |
| DE3889547T2 (de) | 1987-12-24 | 1994-11-17 | Borody Thomas J | Orthostatische waschlösungen. |
| DE68928665T2 (de) | 1988-08-02 | 1998-11-12 | Gastro Services Pty Ltd | Behandlung von gastro-intestinalen krankheiten |
| US5443826A (en) | 1988-08-02 | 1995-08-22 | Borody; Thomas J. | Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli |
| US5213807A (en) | 1990-05-03 | 1993-05-25 | Chemburkar Pramod B | Pharmaceutical composition containing ibuprofen and a prostaglandin |
| US5232699A (en) | 1990-07-26 | 1993-08-03 | The Proctor & Gamble Company | Laxative compositions |
| US5519014A (en) | 1990-10-22 | 1996-05-21 | Borody; Thomas J. | Treatment of non-inflammatory and non-infectious bowel disorders |
| ATE256468T1 (de) | 1990-10-22 | 2004-01-15 | Gastro Services Pty Ltd | Behandlung von nicht-entzündlichen darmerkrankungen |
| US5173296A (en) | 1990-11-16 | 1992-12-22 | The Procter & Gamble Company | Compositions containing psyllium |
| JP3047143B2 (ja) | 1992-04-24 | 2000-05-29 | 堀井薬品工業株式会社 | 腸管洗浄液用組成物及び腸管洗浄液 |
| EP0724441A1 (en) | 1993-10-19 | 1996-08-07 | The Procter & Gamble Company | Picosulphate dosage form |
| JP3850891B2 (ja) | 1994-03-01 | 2006-11-29 | ゼリア新薬工業株式会社 | 緩下効果を有する組成物 |
| AUPM695294A0 (en) | 1994-07-20 | 1994-08-11 | Borody, Thomas Julius | Improved combination therapy dose unit |
| AUPM864894A0 (en) | 1994-10-07 | 1994-11-03 | Borody, Thomas Julius | Treatment of bowel-dependent neurological disorders |
| JP3010007B2 (ja) | 1995-05-22 | 2000-02-14 | ビオフェルミン製薬株式会社 | 配合下剤 |
| RU2098100C1 (ru) | 1995-10-11 | 1997-12-10 | Максимова Ирина Сергеевна | Ирригационный раствор для офтальмологических операций |
| AU771576B2 (en) | 1995-11-03 | 2004-03-25 | Red Hill Biopharma Ltd. | Improved preparation for colonic evacuation |
| NZ333493A (en) | 1995-11-03 | 2000-06-23 | Nicolas Peter Shortis | Method of evacuating a patient's colon by oral administration of an osmotic colonic evacuant in powder form |
| US6103268A (en) | 1995-11-03 | 2000-08-15 | Borody; Thomas Julius | Administering osmotic colonic evacuant containing a picosulfate |
| AUPN634595A0 (en) | 1995-11-03 | 1995-11-30 | Borody, Thomas Julius | Improved method for colonic evacuation |
| JP3423842B2 (ja) | 1996-01-19 | 2003-07-07 | 日研化学株式会社 | 変異株及び該変異株又は親株を用いるエリスリトールの製造方法 |
| US6087386A (en) | 1996-06-24 | 2000-07-11 | Merck & Co., Inc. | Composition of enalapril and losartan |
| EP0845538B1 (en) | 1996-12-02 | 2003-04-02 | Mitsubishi Chemical Corporation | Method of producing erythritol |
| US5948787A (en) | 1997-02-28 | 1999-09-07 | Alza Corporation | Compositions containing opiate analgesics |
| KR19980075195A (ko) | 1997-03-26 | 1998-11-16 | 손경식 | 트리코스포로노이데스 속 변이균주 및 이를 이용한 에리스리톨의 제조방법 |
| US6162464A (en) | 1997-03-31 | 2000-12-19 | Inkine Pharmaceutical, Inc. | Non-aqueous colonic purgative formulations |
| DE69839261T2 (de) | 1997-04-01 | 2009-03-26 | Borody, Thomas Julius, Five Dock | Verfahren und zusammensetzungen zur behandlung entzündlicher darmerkrankungen |
| US6551632B2 (en) | 1997-04-01 | 2003-04-22 | Thomas Julius Borody | Methods and compositions for treating inflammatory bowel disease |
| CN1252711A (zh) * | 1997-04-18 | 2000-05-10 | 大正制药株式会社 | 微乳 |
| AUPO665397A0 (en) | 1997-05-07 | 1997-05-29 | Borody, Thomas Julius | Novel therapy for constipation |
| JP4092748B2 (ja) | 1997-09-05 | 2008-05-28 | ニプロ株式会社 | 腸管洗浄液 |
| KR100541578B1 (ko) | 1997-12-04 | 2006-04-06 | 미쓰비시 가가꾸 가부시키가이샤 | 에리트리톨 생산방법 |
| IL136831A0 (en) | 1997-12-19 | 2001-06-14 | Smithkline Beecham Corp | Process for manufacturing bite-dispersion tablets |
| AUPP325398A0 (en) | 1998-04-30 | 1998-05-21 | Borody, Thomas J. | Improved method for eradicating h. pylori |
| AUPP437698A0 (en) | 1998-06-30 | 1998-07-23 | Baumgart, Karl | Methods for treatment of coronary, carotid and other vascular disease |
| US6001616A (en) | 1998-09-16 | 1999-12-14 | Dong Cheon Consulting Co., Ltd. | Process for preparing erythritol using novel cell of pichia |
| EP1005863A1 (en) | 1998-12-04 | 2000-06-07 | Synthelabo | Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof |
| US6245740B1 (en) | 1998-12-23 | 2001-06-12 | Amgen Inc. | Polyol:oil suspensions for the sustained release of proteins |
| US7763276B1 (en) | 1999-02-26 | 2010-07-27 | Shionogi & Co., Ltd. | Chewable soft capsules having improved administration properties and process for producing the same |
| US6858403B2 (en) | 1999-05-11 | 2005-02-22 | M-Biotech, Inc. | Polymer matrix containing catalase co-immobilized with analytic enzyme that generates hydrogen peroxide |
| DE19930030B4 (de) | 1999-06-30 | 2004-02-19 | Meduna Arzneimittel Gmbh | CO-3-ungesättigte Fettsäuren enthaltende orale Darreichungsform |
| CN1288730A (zh) * | 1999-09-07 | 2001-03-28 | 麦克内尔-Ppc股份有限公司 | 轻泻组合物 |
| JP2001114668A (ja) | 1999-10-13 | 2001-04-24 | Meiji Seika Kaisha Ltd | チョコレート剤 |
| US6774111B1 (en) | 2000-03-14 | 2004-08-10 | Abbott Laboratories | Carbohydrate system and a method for providing nutrition to a diabetic |
| MXPA02010316A (es) | 2000-04-19 | 2005-04-19 | Borody Thomas J | Terapia novedosa para los trastornos asociados con la hiperlipidemia. |
| EP1296693A4 (en) | 2000-06-19 | 2005-05-25 | Mucoprotec Pty Ltd | IMMUNOTHERAPY AND PROBIOTIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL OR VIRAL INFECTIONS ON MUCOSAL SURFACES |
| AUPQ854100A0 (en) | 2000-07-03 | 2000-07-27 | Helirad Pty Ltd | Methods for monitoring treatment of helicobacter infection |
| AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
| MXPA03008227A (es) | 2001-03-13 | 2004-01-29 | Kellog Co | Componente alimentario inflado por aireacion. |
| US6790453B2 (en) | 2001-03-14 | 2004-09-14 | Mccormick & Company, Inc. | Encapsulation compositions and process for preparing the same |
| US7815956B2 (en) | 2001-04-27 | 2010-10-19 | Pepsico | Use of erythritol and D-tagatose in diet or reduced-calorie beverages and food products |
| ATE474559T1 (de) | 2001-06-01 | 2010-08-15 | Pozen Inc | Pharmazeutische zusammensetzungen für die koordinierte abgabe von nsaid |
| JPWO2003004003A1 (ja) | 2001-07-05 | 2004-10-21 | 湧永製薬株式会社 | ソフトカプセル剤 |
| US20030092724A1 (en) | 2001-09-18 | 2003-05-15 | Huaihung Kao | Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic |
| AUPS017702A0 (en) | 2002-01-25 | 2002-02-14 | Atopic Pty Ltd | Methods and compositions for the treatment of asthma and related disorders |
| AUPS088702A0 (en) | 2002-03-04 | 2002-03-28 | Borody, Thomas Julius | Electrolyte purgative |
| US6753009B2 (en) * | 2002-03-13 | 2004-06-22 | Mcneil-Ppc, Inc. | Soft tablet containing high molecular weight polyethylene oxide |
| CN1646102B (zh) | 2002-04-05 | 2012-08-15 | 欧洲凯尔蒂克公司 | 含有羟氢可待酮和烯丙羟吗啡酮的药物制剂 |
| US6946149B2 (en) | 2002-04-30 | 2005-09-20 | Braintree Laboratories, Inc. | Salt solution for colon cleansing |
| AU2003900553A0 (en) | 2003-02-10 | 2003-02-20 | Borody, Thomas Julius | Novel Improved Method for Detection of Dientamoeba fragilis and other Parasites |
| JP4458761B2 (ja) | 2003-03-27 | 2010-04-28 | ロート製薬株式会社 | 瀉下用製剤 |
| CA2521420A1 (en) * | 2003-04-08 | 2004-10-28 | Progenics Pharmaceuticals, Inc. | Combination therapy for constipation comprising a laxative and a peripheral opioid antagonist |
| EP1620075B1 (en) * | 2003-05-07 | 2020-06-24 | Samyang Biopharmaceuticals Corporation | Highly plastic granules for making fast melting tablets |
| US7687075B2 (en) * | 2003-11-19 | 2010-03-30 | Salix Pharmaceuticals, Ltd. | Colonic purgative composition with soluble binding agent |
| UA86802C2 (ru) * | 2004-04-13 | 2009-05-25 | Бёрингер Ингельхайм Интернациональ Гмбх | Комбинация симетикона и бисакодила для предрасположенных к запору пациентов, которые страдают от ощущения вздутия живота |
| ATE476180T1 (de) | 2004-06-04 | 2010-08-15 | Braintree Lab | Verfahren zur darmreinigung |
| KR100749229B1 (ko) | 2005-04-29 | 2007-08-13 | (주)아모레퍼시픽 | 당 및 당알콜을 함유하는 변비개선용 조성물 |
| US20060275223A1 (en) | 2005-06-02 | 2006-12-07 | Burr James B | Erythritol compositions for teeth and gums |
| WO2007057924A1 (en) * | 2005-11-21 | 2007-05-24 | Panacea Biotec Ltd | Laxative composition on the basis of triphala |
| ATE489079T1 (de) | 2005-12-29 | 2010-12-15 | Osmotica Kereskedelmi Es Szolgaltata Kft | Mehrschichtige tablette mit dreifacher freisetzungskombination |
| US20070185145A1 (en) | 2006-02-03 | 2007-08-09 | Royds Robert B | Pharmaceutical composition containing a central opioid agonist, a central opioid antagonist, and a peripheral opioid antagonist, and method for making the same |
| CN101033010A (zh) * | 2006-03-09 | 2007-09-12 | 麦迪森企业股份有限公司 | 塑料容器的内容物封装方法及其容器的制造流程 |
| JP5006567B2 (ja) | 2006-04-14 | 2012-08-22 | 花王株式会社 | 口腔用固形製剤 |
| WO2008021394A2 (en) | 2006-08-15 | 2008-02-21 | Theraquest Biosciences, Llc | Pharmaceutical formulations of cannabinoids and method of use |
| WO2008027442A2 (en) | 2006-08-30 | 2008-03-06 | Theraquest Biosciences, Llc | Abuse deterrent oral pharmaceutical formulations of opioid agonists and method of use |
| JP2008115085A (ja) * | 2006-11-01 | 2008-05-22 | Tendou Seiyaku Kk | 緩下剤 |
| NZ580999A (en) * | 2007-05-17 | 2012-05-25 | David Lubowski | Combination laxative compositions comprising a colonic stimulant and a bulking laxative |
| EP2155167A2 (en) | 2007-06-04 | 2010-02-24 | Egalet A/S | Controlled release pharmaceutical compositions for prolonged effect |
| US20100184785A1 (en) | 2007-06-06 | 2010-07-22 | Basf Se | Pharmaceutical formulation for the production of chewable tablets and lozenges |
| ES2639130T3 (es) | 2007-06-06 | 2017-10-25 | Basf Se | Formulación farmacéutica para la fabricación de comprimidos de rápida desintegración |
| EP2264042B1 (en) | 2007-07-27 | 2012-07-18 | Cargill, Incorporated | Micronization of polyols |
| EP2196221A4 (en) | 2007-09-27 | 2011-12-28 | Mitsubishi Tanabe Pharma Corp | QUICKLY CRUMPING SOLID PREPARATION |
| WO2009043844A2 (en) | 2007-10-01 | 2009-04-09 | Laboratorios Lesvi, S.L. | Orodispersible tablets |
| CA2702935A1 (en) | 2007-10-19 | 2009-04-23 | Purdue Research Foundation | Solid formulations of crystalline compounds |
| JP5258268B2 (ja) | 2007-11-19 | 2013-08-07 | フロイント産業株式会社 | 球形粒の製造方法 |
| US20090155363A1 (en) | 2007-12-14 | 2009-06-18 | Todd Maibach | Methods for oral administration of active drugs |
| US9314454B2 (en) | 2007-12-28 | 2016-04-19 | Sawai Pharmaceutical Co., Ltd. | Oral cavity disintegrating tablet and method of producing the same |
| US20090258090A1 (en) | 2008-04-11 | 2009-10-15 | Braintree Laboratories, Inc. | Colon cleansing solution |
| US20100178413A1 (en) | 2008-12-17 | 2010-07-15 | Mark Gorris | Food-based Supplement Delivery System |
| US20100285164A1 (en) | 2009-05-11 | 2010-11-11 | Jrs Pharma | Orally Disintegrating Excipient |
| US20120064133A1 (en) | 2009-05-28 | 2012-03-15 | Ishwar Chauhan | Multiparticulate Controlled-Release Selective Serotonin Reuptake Inhibitor Formulations |
| US20110218216A1 (en) | 2010-01-29 | 2011-09-08 | Kumaravel Vivek | Extended release pharmaceutical composition of donepezil |
| BR112013014827A2 (pt) | 2010-12-13 | 2016-10-04 | Antony Wettstein | formulações gástricas e colônicas e métodos para produzir e usar as mesmas |
| IN2014DN03373A (enExample) | 2011-10-27 | 2015-06-05 | Borody Thomas J | |
| RU2015106688A (ru) | 2012-07-27 | 2016-09-20 | Редхилл Байофарма Лтд. | Препараты и способы получения препаратов для применения при опорожнении толстой кишки |
| AU2013308403B2 (en) | 2012-08-29 | 2019-02-07 | Salix Pharmaceuticals, Inc. | Laxative compositions and methods for treating constipation and related gastrointestinal diseases and conditions |
-
2011
- 2011-12-13 BR BR112013014827A patent/BR112013014827A2/pt not_active IP Right Cessation
- 2011-12-13 SG SG2013045604A patent/SG191145A1/en unknown
- 2011-12-13 DK DK11848334.6T patent/DK2651415T3/da active
- 2011-12-13 AU AU2011342368A patent/AU2011342368B2/en not_active Ceased
- 2011-12-13 CA CA2821196A patent/CA2821196C/en active Active
- 2011-12-13 CN CN201910226481.0A patent/CN110200954A/zh active Pending
- 2011-12-13 MX MX2013006641A patent/MX355760B/es active IP Right Grant
- 2011-12-13 US US13/993,294 patent/US10092573B2/en active Active
- 2011-12-13 NZ NZ611868A patent/NZ611868A/en not_active IP Right Cessation
- 2011-12-13 KR KR1020137017334A patent/KR101947720B1/ko not_active Expired - Fee Related
- 2011-12-13 PL PL11848334T patent/PL2651415T3/pl unknown
- 2011-12-13 CN CN201180066402.6A patent/CN103338768B/zh not_active Expired - Fee Related
- 2011-12-13 WO PCT/AU2011/001609 patent/WO2012079118A1/en not_active Ceased
- 2011-12-13 EP EP11848334.6A patent/EP2651415B1/en active Active
- 2011-12-13 JP JP2013543468A patent/JP6121334B2/ja not_active Expired - Fee Related
-
2013
- 2013-06-09 IL IL226831A patent/IL226831B/en active IP Right Grant
-
2018
- 2018-10-02 US US16/149,927 patent/US20190240229A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014502598A5 (enExample) | ||
| ES2649063T3 (es) | Formulaciones farmacéuticas que contienen rifaximina, procedimientos para su obtención y método de tratamiento de la enfermedad intestinal | |
| ES2543108T3 (es) | Preparación sólida fácilmente administrable | |
| JP6955648B2 (ja) | 異常炎症反応に関連する状態を処置するための方法および組成物 | |
| CN103338768B (zh) | 胃和结肠的配制剂及其制备和使用方法 | |
| AU2013308403B2 (en) | Laxative compositions and methods for treating constipation and related gastrointestinal diseases and conditions | |
| CN110051638B (zh) | 包含双胍的延迟释放组合物 | |
| TW200413006A (en) | Solid dispersions comprising a hygroscopic and/or deliquescent drug | |
| ES3036967T3 (en) | Delayed release deferiprone tablets and methods of using the same | |
| CN106687107A (zh) | 抗产甲烷组合物及其用途 | |
| US20090197824A1 (en) | Extended Release Pharmaceutical Formulations of S-Adenosylmethionine | |
| JP2018087214A (ja) | スタチン、ビグアナイド、およびさらなる薬剤を含む心血管代謝性リスクを減少させるための組成物 | |
| WO2021145436A1 (ja) | 目的とする既知の薬剤又はその等価物質の新たな適応症の予測方法、予測装置、及び予測プログラム | |
| JP2020507598A (ja) | 局所腸送達のためのペンタアザマクロ環錯体 | |
| FI3706724T3 (fi) | Suun kautta otettavia rifamysiini sv -koostumuksia | |
| US8999384B2 (en) | Immediate release compositions of acid labile drugs | |
| CN104379138B (zh) | 阿坎酸制剂、其使用方法及包含阿坎酸制剂的组合 | |
| Chowrasia et al. | Current drug delivery strategies to design orally dissolving formulations to target tuberculosis: A futuristic review | |
| EA039558B1 (ru) | Композиции в форме таблетки с замедленным высвобождением для перорального введения | |
| ES2829285T3 (es) | Administración de AINE y composiciones, métodos y sistemas relacionados | |
| JP2019513706A5 (enExample) | ||
| JP6093015B2 (ja) | 改良された流動性を有する医薬組成物、薬剤、並びに同一物を製造及び使用するための方法 | |
| US20110020439A1 (en) | Delayed release compositions of duloxetine | |
| CN1319018A (zh) | 提高活性型甘草甜素的生物利用度的口服药物传递系统 | |
| WO2015056013A1 (en) | Composition of thiosulfate salt for oral administration |